Keybanc analyst John Vinh maintains NVIDIA (NASDAQ:NVDA) with a Overweight and raises the price target from $220 to $280.
BMO Capital Downgrades Graphite Bio to Market Perform, Lowers Price Target to $7
BMO Capital analyst Kostas Biliouris downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform and lowers the price target from $14 to $7.